The earnings call reflected significant challenges primarily due to the decline in China sales and impact on profitability, but highlighted strategic initiatives in management restructuring, tariff mitigation, and expansion in global markets. The positive strides in operational efficiency and global sales growth were overshadowed by the severe revenue and profitability declines.

Company Guidance

During the STAAR Surgical first quarter 2025 earnings call, several key metrics and strategic initiatives were discussed. The company reported a total net sales of $42.6 million for Q1 2025, a decrease from $77.4 million in the same period last year, primarily due to minimal purchases by China distributors as they consumed existing inventory. Excluding China, net sales grew by 9% year-over-year. The company highlighted its efforts to manage costs, aiming to reduce SG&A to approximately $225 million by the end of 2025. Adjusted EBITDA for the quarter was a loss of $26.4 million, compared to earnings of $5.3 million in the prior year. Gross margin was 65.8%, down from 78.9% in the previous year, with a target of 70% in the second half of 2025. The company ended the quarter with $222.8 million in cash and investments, expecting a minimum cash balance of $140 million before improving cash flows later in the year. Despite withdrawing formal guidance due to economic uncertainties, STAAR Surgical expressed confidence in its strategic initiatives, particularly in managing China tariffs and expanding its manufacturing capacity in Switzerland.

Streamlined Management Structure

Reorganization of management with promotions to improve operational efficiency, including Warren Faust as President and Deborah Andrews as Interim CFO.

Tariff Mitigation in China

Successfully negotiated consignment agreements and shipped inventory to China to mitigate tariff impacts, ensuring supply through early 2026.

Global Sales Growth (Excluding China)

Reported 9% sales growth outside of China, driven by strong performance in APAC, Americas, and EMEA regions.

Expansion of Swiss Manufacturing

Increased production capacity in Switzerland with expectations to produce over 300,000 lenses annually by the end of 2026.

Introduction of EVO+ Lens in China

Anticipation for the upcoming approval of the EVO+ (V5) lens in China, expected to enhance the product offering in the market.

Staar Surgical (STAA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

STAA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	0.18 / -	0.26	―	―	―
Aug 06, 2025	2025 (Q2)	-0.56 / -0.34	0.39	-186.92% (-0.73)	―	―
May 07, 2025	2025 (Q1)	-0.60 / -0.52	0.107	-583.18% (-0.62)
Feb 11, 2025	2024 (Q4)	-0.03 / -0.51	0.13	-495.38% (-0.64)
Oct 30, 2024	2024 (Q3)	0.18 / 0.26	0.3	-13.33% (-0.04)	―
Aug 07, 2024	2024 (Q2)	0.24 / 0.39	0.4	-2.50% (-0.01)	―
May 07, 2024	2024 (Q1)	0.06 / 0.11	0.18	-40.56% (-0.07)	―
Feb 26, 2024	2023 (Q4)	0.18 / 0.13	0.14	-7.14% (-0.01)	―
Nov 01, 2023	2023 (Q3)	0.18 / 0.30	0.37	-18.92% (-0.07)	―
Aug 02, 2023	2023 (Q2)	0.29 / 0.40	0.42	-4.76% (-0.02)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

STAA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$26.90	$26.95	+0.19%
May 07, 2025	$19.44	$19.53	+0.46%
Feb 11, 2025	$21.88	$16.48	-24.68%
Oct 30, 2024	$29.49	$28.99	-1.70%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Staar Surgical (STAA) report earnings?

Staar Surgical (STAA) is schdueled to report earning on Oct 29, 2025, After Close (Confirmed).

What is Staar Surgical (STAA) earnings time?

Staar Surgical (STAA) earnings time is at Oct 29, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is STAA EPS forecast?

STAA EPS forecast for the fiscal quarter 2025 (Q3) is 0.18.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing